[en] We have developed techniques to label several types of organic molecules with radiobromine. We have emphasized techniques to label ligands for the estrogen receptor and have studied two brominated compounds in rat models. One of these compounds has been studied in a limited number of patients and estrogen containing tumors visualized by nuclear medicine imaging. We have recently expanded the size of the work to label receptor ligands with fluorine-18 and have carried out preliminary animal studies which suggest that a clinically useful compound can be prepared. In addition to the receptor studies, we have collaborated in assessing ⁷⁷Br-labeled compounds as therapeutic agents and in studying ⁷⁷Br-labeled compounds using perturbed angular correlation techniques